This inventor holds 26 USPTO granted patents and 21 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Cystic Fibrosis Research. Top assignees: Vertex Pharmaceuticals, Inc., Aurora Biosciences Corporation, University of California. Active years: 1998-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (1998 - 2007)
- La Jolla, CA (US) (2000 - 2017)
Company Filing History:
8 out of 1,168 
7 out of 33 
7 out of 16,035 
Years Active: 1998-2017
Areas of Expertise:
Title: The Innovative Journey of Gregor Zlokarnik: Pioneering Inventor from La Jolla, CA
Introduction: Gregor Zlokarnik is a prolific inventor based in La Jolla, CA, who has made significant contributions to the field of pharmaceuticals and biotechnology. With a total of 26 patents to his name, Zlokarnik is recognized for his groundbreaking work in developing processes for making modulators of the cystic fibrosis transmembrane conductance regulator.
Latest Patents: Among his latest patents is a novel process for the preparation of a compound essential for modulating the cystic fibrosis transmembrane conductance regulator. This innovative method involves coupling a carboxylic acid with an aniline in the presence of a coupling agent, as outlined in Formula 1, showcasing Zlokarnik's expertise in medicinal chemistry and drug development.
Career Highlights: Zlokarnik's illustrious career has seen him collaborate with esteemed organizations such as Vertex Pharmaceuticals, Inc. and the University of California. His extensive experience in both industry and academia has enabled him to bridge the gap between scientific research and practical applications, leading to the successful commercialization of his inventions.
Collaborations: Throughout his career, Zlokarnik has had the privilege of collaborating with renowned experts in the field, including the likes of Roger Y Tsien and Martyn Botfield. These partnerships have not only fostered innovation but have also paved the way for groundbreaking discoveries in the pharmaceutical industry.
Conclusion: Gregor Zlokarnik's dedication to innovation and his pioneering spirit have established him as a trailblazer in the field of pharmaceuticals. His relentless pursuit of scientific excellence and his passion for pushing the boundaries of knowledge continue to inspire future generations of inventors and researchers. With an impressive portfolio of patents and a legacy of transformative contributions, Zlokarnik remains a driving force in shaping the future of biomedical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile